Crossmark

5-Fluorouracil treatment induces characteristic T>G mutations in human cancer

Crossref DOI link: https://doi.org/10.1038/s41467-019-12594-8

Published Online: 2019-10-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Christensen, Sharon https://orcid.org/0000-0001-5850-973X
Van der Roest, Bastiaan https://orcid.org/0000-0002-8985-8964
Besselink, Nicolle

Janssen, Roel

Boymans, Sander https://orcid.org/0000-0002-3517-2684
Martens, John W. M. https://orcid.org/0000-0002-3428-3366
Yaspo, Marie-Laure https://orcid.org/0000-0002-9555-9979
Priestley, Peter https://orcid.org/0000-0002-4939-7104
Kuijk, Ewart https://orcid.org/0000-0002-1385-6516
Cuppen, Edwin https://orcid.org/0000-0002-0400-9542
Van Hoeck, Arne https://orcid.org/0000-0002-6570-1452
License Information

Text and Data Mining valid from 2019-10-08

Version of Record valid from 2019-10-08
More Information

Article History

Received: 21 June 2019

Accepted: 16 August 2019

First Online: 8 October 2019

Competing interests

: The authors declare no competing interests.